Delos Capital 康禧全球投資基金

Delos Capital 康禧全球投資基金 is a venture capital firm headquartered in the United States. With a small team of 5 employees, the company generates an annual revenue of $2.5 million. Delos Capital focuses on identifying and supporting groundbreaking innovations in science and technology, particularly within the healthcare sector. The firm specializes in funding and nurturing the growth of companies developing drugs and medical devices that address unmet medical needs. Their investment strategy prioritizes therapies that enhance existing treatments by improving safety, efficacy, and cost-effectiveness. Delos Capital's portfolio companies are engaged in developing solutions for a range of medical areas, including oncology, infectious diseases, cardiovascular diseases, ophthalmology, orthopedics, and bariatrics. Delos Capital distinguishes itself through its unique combination of expertise in life sciences, strong global connections, and experience in building international partnerships. This allows them to effectively bridge the gap between entrepreneurs in the East and West, facilitating access to new markets and fostering collaborative innovation. To learn more about Delos Capital and its investment opportunities, visit their website at deloscapital.com.